GAUSH MEDITECH (02407) has issued an announcement, projecting that the group will achieve revenue of approximately RMB 583.2 million to RMB 607 million for the six months ending June 30, 2026. This represents a decrease of approximately 7.1% to 10.7% compared to the revenue of approximately RMB 653.1 million recorded for the six months ending June 30, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.